Differential muscarinic and NMDA contributions to
visuo-spatial paired-associate learning in rhesus monkeys

by
Nehlig A
Taffe MA, Weed MR, Gutierrez T, Davis SA, Gold LH.
Department of Neuropharmacology, CVN-7,
The Scripps Research Institute,
10550 North Torrey Pines Road,
La Jolla, CA 92037, USA.
mtaffe@scripps.edu
Psychopharmacology (Berl) 2002 Mar;160(3):253-62


ABSTRACT

RATIONALE: Early, accurate detection of degenerative neurological disorders such as Alzheimer's disease (AD) is essential for therapies designed to slow disease progression. Performance of a touch-screen mediated visuo-spatial paired-associates learning (vsPAL) task predicts neurocognitive decline in elderly populations presenting with mild cognitive impairment and distinguishes AD patients from elderly depressed individuals. Translation of this cognitive task to a non-human model may therefore provide an improved tool for study of the etiology and treatment of dementia. OBJECTIVE: The goal of the current study was to contrast cholinergic and glutamatergic contributions to performance of this AD-sensitive task by challenging rhesus monkeys performing vsPAL with muscarinic antagonist and non-competitive NMDA antagonist drugs. METHODS: Seven monkeys were trained to perform vsPAL and then serially challenged with acute doses of scopolamine (3, 10, 17 microg/kg, IM) and ketamine (0.3, 1.0, 1.78 mg/kg, IM). RESULTS: Scopolamine produced a dosexdifficulty related impairment of both recognition memory and incremental acquisition aspects of task performance. In contrast, ketamine administration resulted in a dose-dependent impairment of recognition memory but not incremental acquisition. CONCLUSIONS: Monkeys' performance of a task sensitive to AD in humans was impaired by two classic pharmacological models of cognitive impairment, therefore supporting the use of this nonhuman model to explore mechanisms of AD-associated cognitive decline. The differential pattern of impairment observed is consistent with a hypothesis that muscarinic mechanisms are required for linking external events with an existing internal representation, whereas NMDA mechanisms are required for the formation/strengthening of such an internal representation.

Exercise
Ampakines
Vinpocetine
Vasopressin
New brain cells
The memory switch?
Dumb-drug euphoria
Growing new brain cells
Coffee, caffeine and Parkinson's disease




Refs
HOME
HedWeb
Future Opioids
BLTC Research
Utopian Pharmacology
SMART DRUGS 2: review
The Hedonistic Imperative
Critique of Huxley's Brave New World

swan image
The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family